Instrument Inactif

Autres langues Immunomedics, Inc.

Actions

IMMU

US4529071080

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves	27/03/23
Everest Medicines Limited announced that it has received $280 million in funding from Immunomedics, Inc.	27/03/23
Gilead to Acquire Remaining Worldwide Rights of Trodelvy	16/08/22
Protara Therapeutics : Announces Appointment of Martin Sebastian Olivo, M.D. as Chief Medical Officer	20/04/21
Gilead Sciences : Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Outlook for 2020	11/01/21
Gilead Sciences : Advances Oncology Portfolio with New Data from Phase 3 ASCENT Trial of Trodelvy in Metastatic Triple Negative Breast Cancer	11/12/20
Gilead Sciences : to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany	10/12/20
Gilead Sciences : Announces Third Quarter 2020 Financial Results	29/10/20
Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales -- Update	29/10/20
Gilead Sciences : Quarterly Revenue Rises on Remdesivir Sales	28/10/20
Gilead Sciences : Completes Acquisition of Immunomedics, Inc.	26/10/20
IMMUNOMEDICS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23/10/20
Immunomedics, Inc. Announces Board Changes	23/10/20
HBM im Halbjahr 2020/21 mit Gewinnsprung - Zuversichtlich ins zweite Halbjahr	23/10/20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Biotechnology Select Industry Index	23/10/20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P Global BMI Index	23/10/20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from S&P TMI Index	23/10/20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 1000 Index	23/10/20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell Midcap Index	23/10/20
Immunomedics, Inc.(NasdaqGM:IMMU) dropped from Russell 1000 Growth Index	23/10/20

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Immunomedics, Inc.

Actions

IMMU

US4529071080

Autres langues

Filtres